Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Hypertension Potentiates the Risk of Doxorubicin Cardiotoxicity
Link ID 7458
Title Hypertension Potentiates the Risk of Doxorubicin Cardiotoxicity
Url http://www.medscape.com/viewarticle/578496?src=rss
Description Doxorubicin is often withheld from older patients because advanced age -- along with heart disease, diabetes, and hypertension -- are known to increase the risk of doxorubicin-related cardiotoxicity. Now, in a study of older adults with diffuse large B-cell lymphoma (DLBCL), researchers have found that of all these factors, only hypertension synergistically potentiates the risk of cardiac effects. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Aug 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Celecoxib Blocks Morphine-Induced Tumor Growth in Mice
  In a murine model of breast cancer, the COX-2 inhibitor celecoxib prevents chronic morphine-induced effects on tumor growth without compromising analgesia, according to researchers. Reuters Health Information
Category:   Articles > Pharmacists


2. Adverse Events of LTBI Therapy & Postthrombotic Syndrome After Acute DVT
  This video blog by Dr. Andrew Shorr discusses adverse events of therapy for LTBI and postthrombotic syndrome after acute DVT.
Medscape Pulmonary Medicine
Category:   Articles > Pharmacists


3. A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer
  Are newer antidepressants really superior to benzodiazepines in the treatment of anxiety disorders? The current study uses a review of clinical research to question this assumption. Psychopharmacology Bulletin
Category:   Articles > Pharmacists


4. Pramlintide Improves Glycemic Control in Type 2 Diabetic Patients on Insulin
  Treatment with pramlintide improves several aspects of diabetes control and reduces weight in type 2 diabetic patients who are not achieving glycemic targets on basal insulin, according to findings published in the November issue of Diabetes Care. Reuters Health Information
Category:   Articles > Pharmacists


5. Levocarnitine Cuts Annual Hospital Days for Dialysis Patients
  Dialysis patients benefit significantly with the addition of levocarnitine to their dialysis treatments at least once a month, cutting the number of days in the hospital from an average of 15 to roughly ten days. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS